0 Items - $0.00
Categories
A to Z

Alternative structural projections:

cXMP

Xanthosine- 3', 5'- cyclic monophosphate ( cXMP ), sodium salt
Cat. No.: X 001
    
CAS No.: [31319-70-7]
Shipping: ambient
Product Name Price (net) Qty
Cat. No.: X 001-05
Unit: 5 µmol / ~1.8 mg
$126.00
For other salt forms please inquire. Detailed technical information available. Reference: Meyer et al., J. Cyclic Nucl. Res., 1, 159 - 167 (1975); Spangler et al., J. Pharmacol. Exp. Ther., 336, 234 - 241 (2011).
Cat. No. X 001
CAS number [31319-70-7]
Purity > 98% HPLC
Salt form Sodium
Storage temperature -20°C / -4°F
Molecular formula C₁₀H₁₀N₄O₈P · Na
Molecular weight [g/mol] 368,2
Modifications 2-cGMP
Lipophilicity 0.59
Absorption max [nm] 252
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] 11000
  • 1. Almahariq M., Tsalkova T., Mei F. C., Chen H., Zhou J., Sastry S. K., Schwede F.Cheng X., Mol. Pharmacol., 83, 122 - 128 (2013), "A Novel EPAC Specific Inhibitor Suppresses Pancreatic Cancer Cell Migration and Invasion"
  • 2. Beste K. Y., Spangler C. M., Burhenne H., Koch K.-W., Shen Y., Tang W.-J., Kaever V.Seifert R., PLoS ONE, 8, 0 - 0 (2013), "Nucleotidyl Cyclase Activity of Particulate Guanylyl Cyclase A: Comparison with Particulate Guanylyl Cyclases E and F, Soluble Guanylyl Cyclase and Bacterial Adenylyl Cyclases Cyaa and Edema Factor"
  • 3. Reinecke D., Burhenne H., Sandner P., Kaever V.Seifert R., FEBS Lett., 585, 3259 - 3262 (2011), "Human Cyclic Nucleotide Phosphodiesterases Possess a Much Broader Substrate-Specificity than Previously Appreciated"
  • 4. Spangler C., Böhm A., Jenal U., Seifert R.Kaever V., J. Microbiol. Methods, 81, 226 - 231 (2010), "A Liquid Chromatography-coupled Tandem Mass Spectrometry Method for Quantitation of Cyclic Di-guanosine Monophosphate"
  • 5. Schweinsberg S., Moll D., Burghardt N. C., Hahnefeld C., Schwede F., Zimmermann B., Drewianka S., Werner L., Kleinjung F., Genieser H.-G., Schuchhardt J.Herberg F. W., Proteomics, 8, 1212 - 1220 (2008), "Systematic interpretation of cyclic nucleotide binding studies using KinetXBase"
  • 6. Scott S.-P., Shea P. W.Dryer S. E., Biochem., 46, 9417 - 9431 (2007), "Mapping Ligand Interactions with the Hyperpolarization Activated Cyclic Nucleotide Modulated (HCN) Ion Channel Binding Domain Using a Soluble Construct"
  • 7. Rehmann H., Schwede F., Doeskeland S. O., Wittinghofer A.Bos J. L., J. Biol. Chem., 278, 38548 - 38556 (2003), "Ligand-mediated Activation of the cAMP-responsive Guanine Nucleotide Exchange Factor Epac"
  • 8. Hahnefeld C.Herberg F. W., Abstract of the 13th Protein Kinase Symposium p. 14, 0, 12 - 15 (2002), "cAMP-dependent Protein Kinase: cAMP Analog Screening Using Surface Plasmon Resonance and Fluorescent Methods"
  • 9. Schwede F., Ph.D. Thesis, 0, 0 - 0 (1996), "Synthese und Eigenschaften ausgewählter Analoga von cGMP und ihr Einsatz in der biologischen Forschung"
  • 10. Oegreid D., Ekanger R., Suva R. H., Miller J. P.Doeskeland S. O., Eur. J. Biochem., 181, 19 - 31 (1989), "Comparison of the Two Classes of Binding Sites ( A and B ) of Type I and Type II Cyclic AMP-dependent Protein Kinases Using Cyclic Nucleotide Analogs"
  • 11. Erneux C., Miot F., Van Haastert P. J. M.Jastorff B., J. Cyclic Nucleotide Protein Phosphorylation Res., 10, 463 - 472 (1985), "The Binding of Cyclic Nucleotide Analogs to a Purified Cyclic GMP- Stimulated Phosphodiesterase from Bovine Adrenal Tissue"
  • 12. Meyer R. B., Uno H., Shuman D. A., Robins R. K., Simon L. N.Miller J. P., J. Cyclic Nucl. Res., 1, 159 - 167 (1975), "The Synthesis of 2,6-Disubstituted-9-beta-D-Ribofuranosylpurine Cyclic 3',5'-Phosphates and the Selectivity of cAMP and cGMP-specific Enzymes to Substituents in These Positions"
  • 13. Michal G., Mühlegger K., Nelboeck M., Thiessen C.Weimann G., Pharmacol. Res. Commun., 6, 203 - 252 (1974), "Cyclophosphates VI. Cyclophosphates as Substrates and Effectors of Phosphodiesterase"
  • 14. Fikus M., Kwast-Welfeld J., Kazimierczuk Z.Shugar D., Acta Biochim. Polon., 21, 465 - 473 (1974), "Biochemical Studies on Some New Analogues of Adenosine- 3', 5'- Cyclic Phosphate, Including Isoguanosine- 3', 5'- Cyclic Phosphate"
  • 15. Miller J. P., Boswell K. H., Muneyama K., Simon L. N., Robins R. K.Shuman D. A., Biochemistry, 12, 5310 - 5319 (1973), "Synthesis and Biochemical Studies of Various 8-Substituted Derivatives of Guanosine 3', 5' - Cyclic Phosphate, Inosine 3', 5' - Cyclic Phosphate, and Xanthosine 3', 5' - Cyclic Phosphate"
  • 16. Muneyama K., Bauer R. J., Shuman D. A., Robins R. K.Simon L. N., Biochemistry, 10, 2390 - 2395 (1971), "Chemical Synthesis and Biological Activity of 8-Substituted Adenosine 3',5'- Cyclic Monophosphate Derivatives"
  • 17. Michal G., Nelböck M.Weimann G., Z. Anal. Chem., 252, 189 - 193 (1970), "Cyclophosphate III. Spaltung Verschiedener Cyclophosphate durch Phosphodiesterase aus Herz und Fettgewebe"